COPD Exacerbation — SCE Respiratory MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Avoid strong COX-1 inhibitors and obtain specialist phenotype assessment
Asthma, nasal polyposis and a rapid respiratory reaction to a non-selective NSAID suggest NSAID-exacerbated respiratory disease, a pharmacological COX-1 intolerance rather than a drug-specific IgE allergy. Strong COX-1 inhibitors should be avoided; specialist assessment can address cross-reactivity, safe alternatives and whether supervised challenge or desensitisation is justified.
Reference: NHS Specialist Pharmacy Service advice on NSAID use in asthma (Current NHS medicines advice, accessed 30 July 2026): https://www.sps.nhs.uk/articles/using-nsaids-in-asthma/; EAACI position paper on NSAID-exacerbated respiratory disease (Published 2019): https://pmc.ncbi.nlm.nih.gov/articles/PMC7729240/